Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Change in Receivables (2010 - 2025)

Grifols' (GIFLF) quarterly Change in Receivables came in at -$37.2 million in Q4 2025, up 17.0% on a YoY basis from -$31.8 million in Q4 2024, and up 17.0% quarter-over-quarter from -$44.9 million in Q4 2024.

Analysis

Grifols (GIFLF) Change in Receivables (2010 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Change in Receivables for 15 consecutive years, with -$37.2 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 17.0% year-over-year to -$37.2 million; the trailing twelve-month figure through Dec 2025 stood at -$235.4 million (down 19.69% YoY), and the FY2025 full-year result was -$36.2 million, up 19.44% from the prior year.
  • Change in Receivables rose to -$37.2 million in Q4 2025 per GIFLF's latest filing, from -$44.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at -$37.2 million in Q4 2025 and bottomed at -$79.1 million in Q4 2022.
  • Historically, Change in Receivables has averaged -$58.9 million across 4 years, with a median of -$59.6 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Change in Receivables gained 6.1% in 2023, then soared 39.55% in 2024.
  • Over 4 years, Change in Receivables stood at -$79.1 million in 2022, then grew by 6.1% to -$74.2 million in 2023, then jumped by 39.55% to -$44.9 million in 2024, then gained by 17.0% to -$37.2 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$37.2 million, -$44.9 million, and -$74.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 1.09 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 333.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 140.20 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 838.50 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -53.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 31.60 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 269.40 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -37.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -37.25 Mn
Dec 31, 2024 -44.88 Mn
Dec 31, 2023 -74.24 Mn
Dec 31, 2022 -79.06 Mn
Mar 31, 2020 1.48 Mn
Dec 31, 2019 -15.12 Mn
Mar 31, 2019 -163.95 Mn
Dec 31, 2018 16.91 Mn
Jun 30, 2018 -90.04 Mn
Mar 31, 2018 14.96 Mn
Dec 31, 2017 81.48 Mn
Jun 30, 2017 -19.98 Mn
Mar 31, 2017 61.00 Mn
Dec 31, 2016 3.53 Mn
Sep 30, 2016 66.00 Mn
Dec 31, 2015 76.79 Mn
Sep 30, 2015 26.03 Mn
Jun 30, 2015 19.33 Mn
Mar 31, 2015 37.80 Mn
Dec 31, 2014 57.70 Mn